A $5.8 million grant led by Adrie Steyn, Ph.D., of the University of Alabama at Birmingham and the Africa Health Research Institute, or AHRI, in Durban, South Africa, will provide user-requested infected human lung tissue and analytical services to tuberculosis researchers worldwide.

The TB Alliance Fast Track the Cure initiative launched a Request for proposals (RFP): Fast Track the Cure: Community engagement and awareness building for new drug-resistant TB (DR-TB) treatments.

Investigators used PET scans to develop what they believe will be better use of existing drugs to target TB infections in the brain and spine.

WHO releases updated Target Product Profiles for TB diagnosis and detection of drug resistance.

Patients with tuberculosis who used tobacco faced a heightened risk for disease recurrence/relapse and death during treatment, according to a systematic review and meta-analysis published in CHEST.

The International Union Against Tuberculosis and Lung Disease released the August 2024 issue of IJTLD OPEN – a fully-compliant, open access journal to enhance the coverage of TB and lung disease.

RESIST-TB released its August 2024 newsletter with the latest updates and research publications on drug-resistant TB.

Five out of 12 artificial intelligence (AI) products demonstrated higher than an 86 percent area under the receiver operating characteristic curve (AUC) for detecting tuberculosis (TB) on X-rays in a South African patient population with a high TB and human immunodeficiency virus (HIV) burden.

Tuberculosis is the world's top infectious killer. About 10 million people fall ill with the disease every year, and roughly 1.5 million people die because of it, according to the World Health Organization. Additionally, about one-quarter of the world's population is infected with the disease's causative agent Mycobacterium tuberculosis.

The Global Coalition of TB Advocates releases an updated version of its community friendly brochure with the latest advancements and insights in TB prevention.